Transtema (Q3 Initial take): Soft Q3, prospects for improvements in 2026 remain - Redeye
Redeye comments on Transtema’s Q3 report, showing 5.5% organic growth yet a mere 1% adjusted EBITA margin. However, the weak Q3 does not jeopardise the prospects of improving profitability in 2026.
ANNONS
Redeye comments on Transtema’s Q3 report, showing 5.5% organic growth yet a mere 1% adjusted EBITA margin. However, the weak Q3 does not jeopardise the prospects of improving profitability in 2026.
